These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 33541027

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Modifiable factors affecting renal preservation in type I glycogen storage disease after liver transplantation: a single-center propensity-match cohort study.
    Chan YC, Liu KM, Chen CL, Ong AD, Lin CC, Yong CC, Tsai PC, Lu LS, Wu JY.
    Orphanet J Rare Dis; 2021 Oct 11; 16(1):423. PubMed ID: 34635148
    [Abstract] [Full Text] [Related]

  • 3. Type I glycogen storage disease: kidney involvement, pathogenesis and its treatment.
    Chen YT.
    Pediatr Nephrol; 1991 Jan 11; 5(1):71-6. PubMed ID: 2025544
    [Abstract] [Full Text] [Related]

  • 4. Renal disease in an adult with type 1 glycogen storage disease.
    Kiyama S, Kitamoto Y, Nakayama M, Fukui H, Arima S, Tomita M, Inoue T, Sato T.
    Nihon Jinzo Gakkai Shi; 1991 Jan 11; 33(1):81-5. PubMed ID: 2038136
    [Abstract] [Full Text] [Related]

  • 5. Hyperfiltration and renal disease in glycogen storage disease, type I.
    Baker L, Dahlem S, Goldfarb S, Kern EF, Stanley CA, Egler J, Olshan JS, Heyman S.
    Kidney Int; 1989 Jun 11; 35(6):1345-50. PubMed ID: 2671467
    [Abstract] [Full Text] [Related]

  • 6. CRISPR/Cas9 genome editing of SLC37A4 gene elucidates the role of molecular markers of endoplasmic reticulum stress and apoptosis in renal involvement in glycogen storage disease type Ib.
    Skakic A, Andjelkovic M, Tosic N, Klaassen K, Djordjevic M, Pavlovic S, Stojiljkovic M.
    Gene; 2019 Jun 30; 703():17-25. PubMed ID: 30951856
    [Abstract] [Full Text] [Related]

  • 7. Targeted deletion of kidney glucose-6 phosphatase leads to nephropathy.
    Clar J, Gri B, Calderaro J, Birling MC, Hérault Y, Smit GP, Mithieux G, Rajas F.
    Kidney Int; 2014 Oct 30; 86(4):747-56. PubMed ID: 24717294
    [Abstract] [Full Text] [Related]

  • 8. Glucose-6-phosphatase deficiency.
    Froissart R, Piraud M, Boudjemline AM, Vianey-Saban C, Petit F, Hubert-Buron A, Eberschweiler PT, Gajdos V, Labrune P.
    Orphanet J Rare Dis; 2011 May 20; 6():27. PubMed ID: 21599942
    [Abstract] [Full Text] [Related]

  • 9. Emerging therapies for glycogen storage disease type I.
    Koeberl DD, Kishnani PS, Bali D, Chen YT.
    Trends Endocrinol Metab; 2009 Jul 20; 20(5):252-8. PubMed ID: 19541498
    [Abstract] [Full Text] [Related]

  • 10. Hypertension in a child with type IA glycogen storage disease.
    Jonas AJ, Verani RR, Howell RR, Conley SB.
    Am J Kidney Dis; 1988 Mar 20; 11(3):264-6. PubMed ID: 3422787
    [Abstract] [Full Text] [Related]

  • 11. Molecular biology and gene therapy for glycogen storage disease type Ib.
    Chou JY, Cho JH, Kim GY, Mansfield BC.
    J Inherit Metab Dis; 2018 Nov 20; 41(6):1007-1014. PubMed ID: 29663270
    [Abstract] [Full Text] [Related]

  • 12. Glycogen storage disease type I: diagnosis and phenotype/genotype correlation.
    Matern D, Seydewitz HH, Bali D, Lang C, Chen YT.
    Eur J Pediatr; 2002 Oct 20; 161 Suppl 1():S10-9. PubMed ID: 12373566
    [Abstract] [Full Text] [Related]

  • 13. Hypercalcemia in glycogen storage disease type I patients of Turkish origin.
    Kasapkara CS, Tümer L, Okur I, Eminoğlu T, Ezgü FS, Hasanoğlu A.
    Turk J Pediatr; 2012 Oct 20; 54(1):35-7. PubMed ID: 22397040
    [Abstract] [Full Text] [Related]

  • 14. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex.
    Chou JY, Matern D, Mansfield BC, Chen YT.
    Curr Mol Med; 2002 Mar 20; 2(2):121-43. PubMed ID: 11949931
    [Abstract] [Full Text] [Related]

  • 15. Renal complications in glycogen storage disease type I.
    Reitsma-Bierens WC.
    Eur J Pediatr; 1993 Mar 20; 152 Suppl 1():S60-2. PubMed ID: 8319728
    [Abstract] [Full Text] [Related]

  • 16. Long-term complications of glycogen storage disease type Ia in the canine model treated with gene replacement therapy.
    Brooks ED, Landau DJ, Everitt JI, Brown TT, Grady KM, Waskowicz L, Bass CR, D'Angelo J, Asfaw YG, Williams K, Kishnani PS, Koeberl DD.
    J Inherit Metab Dis; 2018 Nov 20; 41(6):965-976. PubMed ID: 30043186
    [Abstract] [Full Text] [Related]

  • 17. Renal endoplasmic reticulum stress is coupled to impaired autophagy in a mouse model of GSD Ia.
    Farah BL, Landau DJ, Wu Y, Sinha RA, Loh A, Bay BH, Koeberl DD, Yen PM.
    Mol Genet Metab; 2017 Nov 20; 122(3):95-98. PubMed ID: 28888852
    [Abstract] [Full Text] [Related]

  • 18. Gene therapy for type I glycogen storage diseases.
    Chou JY, Mansfield BC.
    Curr Gene Ther; 2007 Apr 20; 7(2):79-88. PubMed ID: 17430128
    [Abstract] [Full Text] [Related]

  • 19. Early diagnosis and treatment may prevent the development of complications in an adult patient with glycogen storage disease type Ia.
    Araoka T, Takeoka H, Abe H, Kishi S, Araki M, Nishioka K, Ikeda M, Mazaki T, Ikemura S, Kondo M, Hoshina A, Nagai K, Mima A, Murakami T, Mimura R, Oka K, Saito T, Doi T.
    Intern Med; 2010 Apr 20; 49(16):1787-92. PubMed ID: 20720360
    [Abstract] [Full Text] [Related]

  • 20. A Liver-Specific Thyromimetic, VK2809, Decreases Hepatosteatosis in Glycogen Storage Disease Type Ia.
    Zhou J, Waskowicz LR, Lim A, Liao XH, Lian B, Masamune H, Refetoff S, Tran B, Koeberl DD, Yen PM.
    Thyroid; 2019 Aug 20; 29(8):1158-1167. PubMed ID: 31337282
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.